IDEA 068Alternative Names: Clobetasol - IDEA AG; IDEA 068/003; IDEA 068/072; IDEA-003; IDEA-068; IDEA-072
Latest Information Update: 20 Jun 2008
At a glance
- Originator IDEA
- Class Anti-inflammatories; Antipsoriatics; Fluorinated steroids; Glucocorticoids
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Dermatitis; Psoriasis
Most Recent Events
- 31 Mar 2004 Phase-I clinical trials in Psoriasis in Germany (unspecified route)
- 31 Mar 2004 Phase-I clinical trials in Dermatitis in Germany (unspecified route)